S173: T‐CELL ACTIVATION AND MYELOMA CELL KILLING CONFIRM THE MODE OF ACTION OF RG6234, A NOVEL GPRC5D T‐CELL ENGAGING BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.

Autor:	Dekhtiarenko, I., Lelios, I., Attig, J., Sleiman, N., Lazzaro, D., Clausen, I., Gräfe, N., Helms, H.‐J., Schindler, E., Belli, S., Fauti, T., Eckmann, J., Umana, P., Jacob, W., Schneider, M., Hasselbalch Riley, C., Hutchings, M., Yoon, S.‐S., Koh, Y, Manier, S.
Zdroj:	HemaSphere; 2022 Supplement 3, Vol. 6, p74-75, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text